平特五不中

Jonathan Goodman, MBA'1994

Jonathan Goodman
Jonathan Ross Goodman is currently the Co-founder & CEO of Knight Therapeutics Inc., a Toronto Stock Exchange listed, specialty pharmaceutical company with a market capitalization in excess of $750 million dollars.

Upon graduation from 平特五不中 MBA/Law, Mr. Goodman Co-founded and led Paladin Labs Inc., a Toronto Stock Exchange listed, specialty pharmaceutical company, until its sale to Endo International PLC for $3.2 billion. Under Mr. Goodman鈥檚 leadership Paladin recorded 19 consecutive years of record revenues and saw its share price increase from $1.50 per share to $142 per share.

For the last 20 years, Mr. Goodman has spent approximately 15% of his time trying help repair our broken world. To this end, Paladin has fielded the largest cycling team in Quebec 4 years in a row for the Ride to Conquer Cancer raising millions for this disease that will affect 1 in 3 Canadians. Mr. Goodman has taken an active interest in ORT, a charity that offers vocation training to those in need around the world, and has been instrumental in this organization selling out Place des Arts 4 years in a row raising, last year alone, $1.6 million for various philanthropic cause in Montreal and abroad.

Jonathan has received numerous accolades throughout his outstanding career. He is a recipient of the Desautels Management Achievement Award, the CIBC Spirit of Leadership Community Award, the Globe and Mail鈥檚 Top 40 Under 40 award, the Community Merit Award by Federation Combined Jewish Appeal and was named Quebec Entrepreneur of the Year in the Life Sciences by the National Post.

MBA Next 50 Shapes Footer

Back to top